PARIS — With a strategic alliance, 24-hour production and a bit of luck, Pfizer and BioNTech were able to roll out their Covid vaccine at a brisk pace and relatively free of controversy.
US pharmaceutical giant Pfizer and BioNTech, a smaller German biotech firm, joined forces on April 9, 2020, as the world reeled from the pandemic, with deaths soaring and nations under lockdown.
The companies set an ambitious goal: Producing hundreds of millions of jabs in 2021 — an incredibly short timeline when vaccines usually take years to develop and secure regulatory approval.
Seven months later, Pfizer announced promising results from clinical tests showing the vaccine developed by…
Keep on reading: The Pfizer/BioNTech vaccine bet that paid off